Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Selecting and Finding the Best Healthcare Physicians Requires a Roadmap That Leads to Trust and Accessibility

Host Kevin Stevenson and Dr. Matthew Resnick of Embold Health discuss the difficulty patients face in finding trustworthy, high-quality physicians in an oversaturated healthcare market. They explore how Embold Health's proprietary physician ratings engine brings transparency to physician selection by evaluating appropriateness, effectiveness, and total cost of care. The conversation highlights that roughly 50 percent of back surgeries in the U.S. are deemed unnecessary, underscoring the urgency of better physician evaluation tools.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

By Kevin Stevenson · Embold HealthHealthcareHealthcare PhysiciansI Don't Care
Share

Key takeaways

01

Approximately 50 percent of back surgeries in the U.S. are considered unnecessary, reflecting a broader problem of misaligned physician incentives.

02

Embold Health's physician ratings engine helps patients identify high-quality doctors by assessing appropriateness, effectiveness, and total cost of care.

03

Moving physician evaluation from subjective reputation to data-driven performance metrics is key to improving patient outcomes and reducing waste.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

For an era of information, the paradox of choice reigns supreme, and the field of finding healthcare physicians is no exception. With a multitude of physicians available, patients are often lost in a maze, struggling to find the right doctor for their specific needs. The stakes are high, especially considering that approximately 50 percent of back surgeries in the U.S. are deemed unnecessary. How does one navigate this complex landscape to find the most appropriate, effective, and cost-efficient healthcare?

What do patients really know about their healthcare providers, and how can they be certain they’re choosing the one who will offer the best care for their unique needs? It’s an important question that offers a window into the dilemmas faced by Americans searching for the right physician.

On the latest episode of “I Don’t Care with Kevin Stevenson,” host Kevin Stevenson sat down with Dr. Matthew Resnick, Chief Medical Officer and SVP of Health Plans and Partners at Embold Health. Together, they explored the intricacies of selecting the best healthcare physicians, using Embold Health’s proprietary physician ratings engine. This engine helps patients find physicians delivering quality outcomes and helps physicians assess and compare their performance.

The conversation between the two explored:

  • How Embold Health strives to make physician selection transparent and trustworthy.
  • How performance has been subjective and the move towards evaluating appropriateness, effectiveness, and total cost of care.
  • How Embold Health’s solutions help regular Americans find the right type of doctor and assess their quality of care.

Dr. Matthew Resnick is a urologic oncologist, having treated prostate and bladder cancer predominantly at Vanderbilt’s academic medical center. Resnick is a health services researcher and interested in physicians’ decision-making processes with and for patients. In his role, Resnick also develops tools that shine a light on quality healthcare providers.

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

Kevin Stevenson
Kevin StevensonTop Hospital Administrator & Healthcare COO, I Don't Care

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The EU’s MDR delay buys time, but it won’t clear your commissioning bottleneck

The European Commission backed extending EU MDR transition deadlines to December 2027 and December 2028, Medical Design & Outsourcing reported. It buys time, not ramp-up capacity. Design News cites digital commissioning and machine digital twins to cut “power-on” surprises and speed validation and operator training.

  • 01If an EU portfolio includes Class III, December 2027 is now the planning anchor, but the internal gating item may shift to validation capacity and automation readiness, not paperwork.
  • 02Digital commissioning is becoming a procurement spec, not a buzzword, because it lets teams run DFM/DFA learning loops before hardware is built, which Design News notes is meant to reduce machine power-on surprises.

Sep 5, 2026

HCA’s Q1 was not about volume. It was about coverage and collecting cash

HCA Healthcare reaffirmed 2026 guidance after Q1 weather and a muted respiratory season cut adjusted EBITDA by about $180 million, according to HealthLeaders and Fierce Healthcare. Payer mix shifted fast. Exchange admissions fell about 15% and uninsured admissions rose about 16%, Fierce reported.

  • 01A mild flu season can be a margin event: HCA tied a 42% drop in respiratory admissions to a roughly $180M adjusted EBITDA hit (HealthLeaders, Fierce Healthcare).
  • 02The 2026 risk is sliding from demand to coverage: HCA cited a $600M–$900M full-year EBITDA headwind from exchange-related changes, with $150M already in Q1 (HealthLeaders, Fierce Healthcare).
  • 03Supplemental payments are becoming an operating capability, not a windfall: HCA said Q1 Medicaid program net benefit was about $200M vs $80M expected (HealthLeaders, Fierce Healthcare), putting state-by-state reimbursement strategy on the CFO’s critical path.

Sep 5, 2026

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits are turning into multi-year projects, not last-year decisions

Associate-led dental practice successions can take 3–5+ years. Dental Economics says associate-to-buyout timelines often run three to five-plus years. That pushes revenue-cycle controls, buy-sell terms, and tax structure earlier, before a buyer appears.

  • 01A practical benchmark is emerging for succession: bringing in an associate with intent to buy can take a minimum of three years and often more than five, according to Dental Economics.
  • 02If accounts receivable looks “high,” it may be a bookkeeping and posting problem before it is a payer problem, a revenue-cycle diagnostic Group Dentistry Now says shows up frequently at scale.
  • 03Exit planning is now an operating system project: valuation, tax positioning, and transition support belong in the same workstream, because deal structure can lock in or foreclose tax options, per Dental Economics.

Sep 4, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

Kevin Stevenson
Kevin Stevenson

Host, I Don't Care with Kevin Stevenson

I Don't Care

Kevin Stevenson is the host of 'I Don't Care with Kevin Stevenson,' a MarketScale podcast focused on the challenges facing healthcare executives and administrators. He interviews leaders and innovators enabling hospitals, urgent care centers, and telemedicine operators to improve patient care. Stevenson covers topics ranging from physician selection to healthcare logistics and operational efficiency.

DM
Dr. Matthew Resnick

Chief Medical Officer and SVP of Health Plans and Partners

Embold Health

Dr. Matthew Resnick is a urologic oncologist who previously treated prostate and bladder cancer at Vanderbilt's academic medical center. He is a health services researcher focused on physicians' decision-making processes with and for patients. At Embold Health, he develops tools that identify and surface high-quality healthcare providers for patients and health plans.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512